Advertisement

The Role of Registries in Kidney Transplantation Across International Boundaries

      Summary: Transplant professionals strive to improve domestic kidney transplantation rates safely, cost efficiently, and ethically, but to increase rates further may wish to allow their recipients and donors to traverse international boundaries. Travel for transplantation presents significant challenges to the practice of transplantation medicine and donor medicine, but can be enhanced if sustainable international registries develop to include low- and low-middle income countries. Robust data collection and sharing across registries, linking pretransplant information to post-transplant information, linking donor to recipient information, increasing living donor transplant activity through paired exchange, and ongoing reporting of results to permit flexibility and adaptability to changing clinical environments, will all serve to enhance kidney transplantation across international boundaries.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Nephrology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Liyanage T
        • Ninomiya T
        • Jha V
        • et al.
        Worldwide access to treatment for end-stage kidney disease: a systematic review.
        Lancet. 2015; 385: 1975-1982https://doi.org/10.1016/S0140-6736(14)61601-9
        • Wolfe RA
        • Ashby VB
        • Milford EL
        • et al.
        Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
        N Engl J Med. 1999; 341: 1725-1730https://doi.org/10.1056/NEJM199912023412303
        • Tonelli M
        • Wiebe N
        • Knoll G
        • et al.
        Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes.
        Am J Transplant. 2011; 11: 2093-2109https://doi.org/10.1111/j.1600-6143.2011.03686.x
        • Mudiayi D
        • Shojai S
        • Okpechi I
        • et al.
        global estimates of capacity for kidney transplantation in world countries and regions.
        Transplantation. 2022; 106: 1113-1122https://doi.org/10.1097/TP.0000000000003943
        • Gliklich RE
        • Bibeau K
        • Eisenberg F
        • et al.
        Outcome measures framework: information model report: registry of patient registries [internet].
        Agency for Healthcare Research and Quality (US), 2018 (Accessed January 2, 2022.)
        • Dale DC
        • Bolyard AA
        • Steele LA
        • Zeidler C
        • Welte K
        Severe Chronic Neutropenia International Registry. Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry.
        Curr Opin Hematol. 2020; 27: 18-26https://doi.org/10.1097/MOH.0000000000000558
        • Donaldson L.
        Registering a need.
        BMJ. 1992; 305: 597-598https://doi.org/10.1136/bmj.305.6854.597
        • Lim TO
        • Goh A
        • Lim YN
        • Morad Z.
        Review article: use of renal registry data for research, health-care planning and quality improvement: what can we learn from registry data in the Asia-Pacific region?.
        Nephrology (Carlton). 2008; 13: 745-752https://doi.org/10.1111/j.1440-1797.2008.01044.x
        • Solomon DJ
        • Henry RC
        • Hogan JG
        • Van Amburg GH
        • Taylor J.
        Evaluation and implementation of public health registries.
        Public Health Rep. 1991; 106: 142-150
      1. Gliklich RE Dreyer NA Leavy MB Registries for Evaluating Patient Outcomes: A User’s Guide [Internet]. 3rd ed. Agency for Healthcare Research and Quality (US), 2014 (Accessed January 2, 2022.)
        • Leung CB
        • Cheung WL
        • Li PK.
        Renal registry in Hong Kong-the first 20 years.
        Kidney Int Suppl. 2015; 5 (2011): 33-38https://doi.org/10.1038/kisup.2015.7
        • McDonald SP
        • Russ GR.
        Australian registries-ANZDATA and ANZOD.
        Transplant Rev (Orlando). 2013; 27: 46-49https://doi.org/10.1016/j.trre.2013.01.003
      2. National Institute of Neurological Disorders and Stroke. Common Data Elements. Accessed January 2, 2022. https://www.commondataelements.ninds.nih.gov/#page=Default.

        • Gliklich RE
        • Leavy MB
        • Karl J
        • Campion DM
        • Levy D
        • Berliner E.
        A framework for creating standardized outcome measures for patient registries.
        J Comp Eff Res. 2014; 3: 473-480https://doi.org/10.2217/cer.14.38
        • Hernández D
        • Sánchez E
        • Armas-Padrón AM.
        Kidney transplant registries: how to optimise their utility?.
        Nefrologia (Engl Ed). 2019; 39: 581-591https://doi.org/10.1016/j.nefro.2018.11.008
        • Hiemstra B
        • Keus F
        • Wetterslev J
        • Gluud C
        • van der Horst ICC.
        DEBATE-statistical analysis plans for observational studies.
        BMC Med Res Methodol. 2019; 19: 233https://doi.org/10.1186/s12874-019-0879-5
        • Meerpohl JJ
        • Blümle A
        • Antes G
        • EV Elm
        Leitlinien für Forschungsberichte sind auch für Leser medizinischer Fachartikel hilfreich: CONSORT, STARD, STROBE & Co [Reporting guidelines are also useful for readers of medical research publications: CONSORT, STARD, STROBE and others].
        Dtsch Med Wochenschr. 2009; 134: 2078-2083https://doi.org/10.1055/s-0029-1237560
        • Stroup DF
        • Berlin JA
        • Morton SC
        • et al.
        Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
        JAMA. 2000; 283: 2008-2012https://doi.org/10.1001/jama.283.15.2008
        • Collins GS
        • Reitsma JB
        • Altman DG
        • Moons KG.
        Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.
        BMC Med. 2015; 13: 1https://doi.org/10.1186/s12916-014-0241-z
        • Mokdad AH
        • Marks JS
        • Stroup DF
        • Gerberding JL.
        Actual causes of death in the United States, 2000.
        JAMA. 2004; 291 (Erratum in: JAMA. 2005;293(3):298. Erratum in: JAMA. 2005;293(3):293-294.): 1238-1245https://doi.org/10.1001/jama.291.10.1238
        • Schold JD
        • Buccini LD
        • Kattan MW
        • et al.
        The association of community health indicators with outcomes for kidney transplant recipients in the United States.
        Arch Surg. 2012; 147: 520-526https://doi.org/10.1001/archsurg.2011.2220
        • Ciszek M
        • Kisiel B
        • Czerwinski J
        • et al.
        Kidney transplant recipients with rheumatic diseases: epidemiological data from the Polish Transplant Registries 1998-2015.
        Transplant Proc. 2018; 50: 1654-1657https://doi.org/10.1016/j.transproceed.2018.03.122
        • Schold JD
        • Srinivas TR
        • Kayler LK
        • Meier-Kriesche HU
        The overlapping risk profile between dialysis patients listed and not listed for renal transplantation.
        Am J Transplant. 2008; 8: 58-68https://doi.org/10.1111/j.1600-6143.2007.02020.x
        • Sokas C
        • Cooper Z
        • Salim A
        • Rodrigue JR
        • Adler JT.
        Wait expectations: the impact of delisting as an outcome from the kidney transplant waitlist.
        Clin Transplant. 2021; 35: e14250https://doi.org/10.1111/ctr.14250
        • Hernández D
        • Castro-de la Nuez P
        • Muriel A
        • Ruiz-Esteban P
        • Alonso M
        Mortality on a renal transplantation waiting list.
        Nefrologia. 2015; 35: 18-27https://doi.org/10.3265/Nefrologia.pre2014.Oct.12681
        • Ng MSY
        • Charu V
        • Johnson DW
        • O'Shaughnessy MM
        • Mallett AJ
        National and international kidney failure registries: characteristics, commonalities, and contrasts.
        Kidney Int. 2022; 101: 23-35https://doi.org/10.1016/j.kint.2021.09.024
        • Htay H
        • Pascoe EM
        • Hawley CM
        • et al.
        Patient and center characteristics associated with kidney transplant outcomes: a binational registry analysis.
        Transpl Int. 2020; 33: 1667-1680https://doi.org/10.1111/tri.13681
        • Clayton PA
        • Saunders JR
        • McDonald SP
        • et al.
        Risk-factor profile of living kidney donors: the Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012.
        Transplantation. 2016; 100: 1278-1283https://doi.org/10.1097/TP.0000000000000877
        • McDonald SP
        • Craig JC
        Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease.
        N Engl J Med. 2004; 350: 2654-2662https://doi.org/10.1056/NEJMoa031643
        • De La Mata NL
        • Clayton PA
        • Kelly PJ
        • et al.
        Survival in living kidney donors: an Australian and New Zealand Cohort Study Using Data Linkage.
        Transplant Direct. 2020; 6: e533https://doi.org/10.1097/TXD.0000000000000975
        • Vajdic CM
        • McDonald SP
        • McCredie MR
        • et al.
        Cancer incidence before and after kidney transplantation.
        JAMA. 2006; 296: 2823-2831https://doi.org/10.1001/jama.296.23.2823
        • Clayton P
        • McDonald S
        • Chadban S.
        Steroids and recurrent IgA nephropathy after kidney transplantation.
        Am J Transplant. 2011; 11: 1645-1649https://doi.org/10.1111/j.1600-6143.2011.03667.x
        • Allen PJ
        • Chadban SJ
        • Craig JC
        • et al.
        Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.
        Kidney Int. 2017; 92: 461-469https://doi.org/10.1016/j.kint.2017.03.015
        • Jakobsen JC
        • Gluud C
        • Wetterslev J
        • Winkel P.
        When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts.
        BMC Med Res Methodol. 2017; 17: 162https://doi.org/10.1186/s12874-017-0442-1
        • Oniscu GC
        • Brown H
        • Forsythe JL.
        How great is the survival advantage of transplantation over dialysis in elderly patients?.
        Nephrol Dial Transplant. 2004; 19: 945-951https://doi.org/10.1093/ndt/gfh022
        • Pladys A
        • Bayat S
        • Couchoud C
        • Vigneau C
        • McDonald S.
        Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study.
        BMC Nephrol. 2019; 20: 156https://doi.org/10.1186/s12882-019-1330-1
        • Kim SJ
        • Schaubel DE
        • Fenton SS
        • Leichtman AB
        • Port FK.
        Mortality after kidney transplantation: a comparison between the United States and Canada.
        Am J Transplant. 2006; 6: 109-114https://doi.org/10.1111/j.1600-6143.2005.01141.x
        • Huria T
        • Palmer SC
        • Pitama S
        • et al.
        Consolidated criteria for strengthening reporting of health research involving indigenous peoples: the CONSIDER statement.
        BMC Med Res Methodol. 2019; 19: 173https://doi.org/10.1186/s12874-019-0815-8
        • Zumla A
        • Costello A.
        Ethics of healthcare research in developing countries.
        J R Soc Med. 2002; 95: 275-276https://doi.org/10.1258/jrsm.95.6.275
        • Harolds JA.
        Quality and safety in health care, part XXXIV: the PINNACLE Registry.
        Clin Nucl Med. 2018; 43: 246-247https://doi.org/10.1097/RLU.0000000000001884
        • de Carvalho EC
        • Batilana AP
        • Simkins J
        • et al.
        Application description and policy model in collaborative environment for sharing of information on epidemiological and clinical research data sets.
        PLoS One. 2010; 5: e9314https://doi.org/10.1371/journal.pone.0009314
        • Baid-Agrawal S
        • Frei UA.
        Living donor renal transplantation: recent developments and perspectives.
        Nat Clin Pract Nephrol. 2007; 3: 31-41https://doi.org/10.1038/ncpneph0383
        • Hart A
        • Lentine KL
        • Smith JM
        • et al.
        OPTN/SRTR 2019 annual data report: kidney.
        Am J Transplant. 2021; 21: 21-137https://doi.org/10.1111/ajt.16502
        • Mjøen G
        • Hallan S
        • Hartmann A
        • et al.
        Long-term risks for kidney donors.
        Kidney Int. 2014; 86: 162-167https://doi.org/10.1038/ki.2013.460
        • Muzaale AD
        • Massie AB
        • Wang MC
        • et al.
        Risk of end-stage renal disease following live kidney donation.
        JAMA. 2014; 311: 579-586https://doi.org/10.1001/jama.2013.285141
        • Ibrahim HN
        • Foley R
        • Tan L
        • et al.
        Long-term consequences of kidney donation.
        N Engl J Med. 2009; 360: 459-469https://doi.org/10.1056/NEJMoa0804883
        • Lentine KL
        • Lam NN
        • Segev DL.
        Risks of living kidney donation: current state of knowledge on outcomes important to donors.
        Clin J Am Soc Nephrol. 2019; 14: 597-608https://doi.org/10.2215/CJN.11220918
        • Kasiske BL
        • Asrani SK
        • Dew MA
        • et al;
        Living Donor Collective Participants. The Living Donor Collective: a scientific registry for living donors.
        Am J Transplant. 2017; 17: 3040-3048https://doi.org/10.1111/ajt.14365
        • Dharia AA
        • Huang M
        • Nash MM
        • Dacouris N
        • Zaltzman JS
        • Prasad GVR.
        Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneys.
        BMC Nephrol. 2022; 23: 97https://doi.org/10.1186/s12882-022-02718-6
        • Kasiske BL
        • Ahn YS
        • Conboy M
        • et al.
        Outcomes of living kidney donor candidate evaluations in the Living Donor Collective Pilot Registry.
        Transplant Direct. 2021; 7: e689https://doi.org/10.1097/TXD.0000000000001143
        • Mathur AK
        • Stewart Lewis ZA
        • Warren PH
        • et al.
        Best practices to optimize utilization of the National Living Donor Assistance Center for the financial assistance of living organ donors.
        Am J Transplant. 2020; 20: 25-33https://doi.org/10.1111/ajt.15684
        • Prasad GVR.
        Understanding the sex disparity in living kidney donation.
        J Eval Clin Pract. 2018; 24: 999-1004https://doi.org/10.1111/jep.13015
        • Bailey PK
        • Wong K
        • Robb M
        • et al.
        Has the UK living kidney donor population changed over time? A cross-sectional descriptive analysis of the UK living donor registry between 2006 and 2017.
        BMJ Open. 2020; 10e033906https://doi.org/10.1136/bmjopen-2019-033906
        • Gaillard F
        • Jacquemont L
        • Roberts V
        • et al.
        Temporal trends in living kidney donation in France between 2007 and 2017.
        Nephrol Dial Transplant. 2021; 36: 730-738https://doi.org/10.1093/ndt/gfz229
        • Hanson CS
        • Chapman JR
        • Gill JS
        • et al.
        Identifying outcomes that are important to living kidney donors: a nominal group technique study.
        Clin J Am Soc Nephrol. 2018; 13: 916-926https://doi.org/10.2215/CJN.13441217
      3. NHS Blood and Transplant, Annual Report on Living Donor Kidney Transplantation 2020/21, 2022. Accessed August 3, 2022. https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/25370/annual-report-on-living-donor-kidney-transplantation-2020-21.pdf.

        • Waterman AD
        • Dew MA
        • Davis CL
        • et al.
        Living-donor follow-up attitudes and practices in U.S. kidney and liver donor programs.
        Transplantation. 2013; 95: 883-888https://doi.org/10.1097/TP.0b013e31828279fd
        • Henderson ML
        • Thomas AG
        • Shaffer A
        • et al.
        The national landscape of living kidney donor follow-up in the United States.
        Am J Transplant. 2017; 17: 3131-3140https://doi.org/10.1111/ajt.14356
        • Chico V.
        The impact of the General Data Protection Regulation on health research.
        Br Med Bull. 2018; 128: 109-118https://doi.org/10.1093/bmb/ldy038
      4. Organisation for Economic Cooperation and Development. A road map for a country-led data revolution, 2015. Accessed: September 2, 2021. https://read.oecd-ilibrary.org/development/a-road-map-for-a-country-led-data-revolution_9789264234703-en#page1.

        • Talbot B
        • Athavale A
        • Jha V
        • Gallagher M.
        Data challenges in addressing chronic kidney disease in low- and lower-middle-income countries.
        Kidney Int Rep. 2021; 6: 1503-1512https://doi.org/10.1016/j.ekir.2021.03.901
        • Divyaveer SS
        • Ramachandran R
        • Sahay M
        • et al
        • South Asia Regional Board ISN
        International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in South Asia.
        Kidney Int Suppl. 2021; 11 (2011): e97-e105https://doi.org/10.1016/j.kisu.2021.01.006
        • Davids MR
        • Eastwood JB
        • Selwood NH
        • et al.
        A renal registry for Africa: first steps.
        Clin Kidney J. 2016; 9: 162-167https://doi.org/10.1093/ckj/sfv122
        • Australian Commission on Safety and Quality in Health Care (ACSQHC)
        Economic evaluation of clinical quality registries: final report.
        ACSQHC, 2016 (Accessed February 1, 2022)
        • Nataatmadja M
        • Cho Y
        • Johnson DW.
        Continuous quality improvement initiatives to sustainably reduce peritoneal dialysis-related infections in Australia and New Zealand.
        Perit Dial Int. 2016; 36: 472-477https://doi.org/10.3747/pdi.2016.00114
        • Ashraf H.
        Countries need better information to receive development aid.
        Bull World Health Organ. 2005; 83 (Accessed September 2, 2021.): 565-566
        • OECD
        Partnership in Statistics for Development in the 21st Century (PARIS21).
        Secretary General's Report to Ministers 2019. OECD Publishing, 2019https://doi.org/10.1787/078f091a-en
        • Hoeijmakers F
        • Beck N
        • Wouters MWJM
        • Prins HA
        • Steup WH.
        National quality registries: how to improve the quality of data?.
        J Thorac Dis. 2018; 10: S3490-S3499https://doi.org/10.21037/jtd.2018.04.146
      5. World Health Organization global strategy on digital health. World Health Organization (2020-2025). Accessed February 16, 2021.https://cdn.who.int/media/docs/default-source/documents/gs4dhdaa2a9f352b0445bafbc79ca799dce4d_02adc66d-800b-4eb5-82d4-f0bc778a5a2c.pdf?sfvrsn=f112ede5_68.

        • Harris DCH
        • Davies SJ
        • Finkelstein FO
        • et al
        Strategic Plan Working Groups. Strategic plan for integrated care of patients with kidney failure.
        Kidney Int. 2020; 98: S117-S134https://doi.org/10.1016/j.kint.2020.07.023
        • Pecoits-Filho R
        • Okpechi IG
        • Donner JA
        • et al.
        Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes.
        Kidney Int Suppl. (2011). 2020; 10: e3-e9https://doi.org/10.1016/j.kisu.2019.11.001
        • International Summit on Transplant Tourism and Organ Trafficking
        The declaration of Istanbul on organ trafficking and transplant tourism.
        Clin J Am Soc Nephrol. 2008; 3: 1227-1231https://doi.org/10.2215/CJN.03320708
        • Prasad GV
        • Shukla A
        • Huang M
        • D'A Honey RJ
        • Zaltzman JS
        Outcomes of commercial renal transplantation: a Canadian experience.
        Transplantation. 2006; 82: 1130-1135https://doi.org/10.1097/01.tp.0000241072.03400.11
        • Prasad GVR
        • Ananth S
        • Palepu S
        • Huang M
        • Nash MM
        • Zaltzman JS.
        Commercial kidney transplantation is an important risk factor in long-term kidney allograft survival.
        Kidney Int. 2016; 89: 1119-1124https://doi.org/10.1016/j.kint.2015.12.047
        • Al Ammary F
        • Thomas AG
        • Massie AB
        • et al.
        The landscape of international living kidney donation in the United States.
        Am J Transplant. 2019; 19: 2009-2019https://doi.org/10.1111/ajt.15256
        • Lentine KL
        • Motter JD
        • Henderson ML
        • et al.
        Care of international living kidney donor candidates in the United States: a survey of contemporary experience, practice, and challenges.
        Clin Transplant. 2020; 34: e14064https://doi.org/10.1111/ctr.14064
        • Vanholder R
        • Stel VS
        • Jager KJ
        • et al.
        How to increase kidney transplant activity throughout Europe–an advocacy review by the European Kidney Health Alliance.
        Nephrol Dial Transplant. 2019; 34: 1254-1261https://doi.org/10.1093/ndt/gfy390
        • Yeates KE
        • Cass A
        • Sequist TD
        • et al.
        Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation.
        Kidney Int. 2009; 76: 659-664https://doi.org/10.1038/ki.2009.236
        • Stehlik J
        • Mehra MR
        • Sweet SC
        • et al.
        The International Society for Heart and Lung Transplantation Registries in the era of big data with global reach.
        J Heart Lung Transplant. 2015; 34: 1225-1232https://doi.org/10.1016/j.healun.2015.08.001
        • Toews M
        • Giancaspro M
        • Richards B
        • Ferrari P.
        Kidney paired donation and the “valuable consideration” problem: the experiences of Australia, Canada, and the United States.
        Transplantation. 2017; 101: 1996-2002https://doi.org/10.1097/TP.0000000000001778
        • Montgomery RA
        • Gentry SE
        • Marks WH
        • et al.
        Domino paired kidney donation: a strategy to make best use of live non-directed donation.
        Lancet. 2006; 368: 419-421https://doi.org/10.1016/S0140-6736(06)69115-0
        • Prasad GV.
        Distinguishing internal property from external property in kidney transplantation.
        J Eval Clin Pract. 2016; 22: 539-543https://doi.org/10.1111/jep.12571
        • Bozek DN
        • Dunn TB
        • Kuhr CS
        • et al.
        Complete chain of the first global kidney exchange transplant and 3-yr follow-up.
        Eur Urol Focus. 2018; 4: 190-197https://doi.org/10.1016/j.euf.2018.07.021
        • Prasad GV.
        A moral dilemma argument against clinical trials of incentives for kidney donation.
        Transplant Res. 2015; 4: 3https://doi.org/10.1186/s13737-015-0025-9
        • Mohan S
        • King KL
        • Husain SA
        • Schold JD.
        COVID-19-associated mortality among kidney transplant recipients and candidates in the United States.
        Clin J Am Soc Nephrol. 2021; 16: 1695-1703https://doi.org/10.2215/CJN.02690221
        • Udomkarnjananun S
        • Kerr SJ
        • Townamchai N
        • et al.
        Mortality risk factors of COVID-19 infection in kidney transplantation recipients: a systematic review and meta-analysis of cohorts and clinical registries.
        Sci Rep. 2021; 11: 20073https://doi.org/10.1038/s41598-021-99713-y
        • Caillard S
        • Chavarot N
        • Francois H
        • et al.
        • French SOT COVID Registry
        Is COVID-19 infection more severe in kidney transplant recipients?.
        Am J Transplant. 2021; 21: 1295-1303https://doi.org/10.1111/ajt.16424